|
DC CFAR Developmental Core "My Path to Independence in HIV Research" Featuring Dr. Anthony Fauci
Thursday, March 21, from 4:00-5:00PM ET
| |
|
Please join us for the DC CFAR Developmental Core Lecture Series: My Path to Independence in HIV Research. Each hour-long session in this series will showcase prominent researchers from across the country and autobiographical accounts of their careers in HIV research, specifically their pathways to career and research independence.
Our next lecture will feature Dr. Anthony Fauci, Distinguished University Professor in the Division of Infectious Diseases at Georgetown University School of Medicine and former Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH). Dr. Fauci will discuss his perspectives on pursuing a research career in HIV-related science. We plan to follow his 30-minute presentation with a 30-minute Q&A session. We kindly ask that participants submit questions for Dr. Fauci in advance in the registration form linked below. Questions can be submitted in the chat box during the session as well.
For more information, please find his website here.
Register for the seminar here.
| |
DC CFAR Implementation Science and Community Partnership Seminar Series: IS Study Design, Thu Feb 22, from 5:30-7:00 PM EST (VIRTUAL) | |
Please join us for our upcoming IS and Community Partnership Seminar on Study Design! This VIRTUAL seminar will be held on February 22, from 5:30-7PM EST. We will be hearing from Subject Matter Expert, Denis Nash, PhD, MPH from CUNY-SPH. We will also be hearing from Nina Yamanis, PhD, MPH, Associate Professor at American University, and DC CFAR SBS Core Co-Director. Please RSVP at the link below.
Register here
| |
Announcing the Spring 2024 Cycle of the DC CFAR Traditional Pilot Awards Program: Presubmissions Due TODAY, by 5PM EST | |
The DC CFAR is pleased to announce the next round of the Traditional Pilot Awards Program. The goal of the Traditional Pilot Awards is to provide pilot research funds (up to $75,000) to early stage and new HIV/AIDS investigators to collect preliminary data that will enable them to then compete successfully for NIH funding in HIV/AIDS as principal investigators. Please see the RFA for specific eligibility requirements. Pre-submissions are due TODAY, February 21 at 5 pm EST.
The Developmental Core recently hosted a Research Awards 101 Session to provide an overview of this program and services available to support applications. The recording and slides are available through these links. For complete details about this funding opportunity, please visit our website. All documents including the Pre-Submission Form, RFA and Application Form are available online.
If you have any questions regarding the application process, please contact Lorena Segarra, Senior Research Program Manager.
| | |
DC CFAR Investigator, Dr. Kendall Moody, Receives Mid-Atlantic CFAR Consortium (MACC) Scholars Award | |
Please join us in congratulating DC CFAR Investigator, Dr. Kendall Moody (Howard) for being selected to the third cohort of the Mid-Atlantic CFAR Consortium (MACC) Scholars Program. Dr. Moody is an Assistant Professor in the School of Social Work at Howard University, and the project he will be pursuing as a part of the MACC Scholars Program is entitled, "Understanding and conceptualizing life chaos and its impact on viral suppression among adults living with HIV in Washington, DC."
To view past DC CFAR MACC Scholars, please visit the DC CFAR website here.
| |
DC CFAR Investigator Dr. Rachel Scott's Study Added to CDC Compendium | |
DC CFAR Investigator, Dr. Rachel Scott's (Georgetown) study entitled "HIV PrEP Services for Urban Women" was added to the CDC's Compendium of Evidence-Based Interventions and Best Practices for HIV Prevention, under PrEP Services, linked here.
The study that these recommendations draw from are from Dr. Scott's study entitled, "Implementation of an Educational Intervention to Improve HIV Pre-Exposure Prophylaxis Services for Women in an Urban Sexual Health Clinic," which can be read online in the Journal of AIDS Patient Care and STDs.
| | |
DC CFAR Investigator, Dr. Sarah Calabrese, Publishes Two New Articles | |
DC CFAR Investigator, Dr. Sarah Calabrese (GWU) has recently published two new articles. The first article is entitled, "The Potential Role of Undetectable = Untransmittable (U = U) in Reducing HIV Stigma among Sexual Minority Men in the US," and the second article is entitled "The Implications of PrEP Use, Condom Use, and Partner Viral Load Status for Openness to Serodifferent Partnering Among US Sexual Minority Men," both published in the Journal of AIDS and Behavior. These were published in collaboration with other GW investigators, national and international university partners, and CBOs. Please use the above links to read more.
| |
DC CFAR Investigator, Dr. Lee Campbell Publishes New Article | |
DC CFAR Investigator, Dr. Lee Campbell (Georgetown) recently publsihed a new paper entitled, "Gesicles packaging dCas9-VPR ribonucleoprotein complexes can combine with vorinostat and promote HIV proviral transcription," in the Journal of Molecular Therapy Methods & Clinical Development, with colleagues at the Laboratory of Preclinical Neurobiology, Department of Neuroscience at Georgetown University. This paper found that a combination of dCas9-VPR gesicles with other latency-reversing agents may provide a complementary method to activate latent HIV in future studies utilizing patient-derived cells or small animal models. Use the link here to read the full article.
| | |
Do you have an event you would like to see included in the next edition of the Community Spotlight? We invite any news or updates from the DC CFAR community and encourage you to send information that may be of interest to CFARinDC@gmail.com. | |
|
CROI: Conference on Retroviruses and Opportunistic Infections 2024 (Abstract Submission here)
March 3-6, 2024
Denver, CO
Inter-CFAR Substance Use Research Community (I-SURC) Networking Meeting (During CROI) - Are you attending CROI and interested networking with other substance use researchers? Register now!
March 3, 2024
Denver, CO
Save the Date – National 2024 Ryan White Conference on HIV & Treatment (AIDSWatch)
March 17-19, 2024
Washington, DC
Save the Date: MACC School of Nursing (SON) Conference
May 2-3, 2024
Baltimore, MD
ACTHIV 2024: Registration Open
May 2-4, 2024
Atlanta, GA | Hybrid
SYNC 2024: Registration Now Open & Call for Abstracts
May 29-31, 2024
Washington, DC
19th International Conference on HIV Treatment & Prevention Adherence – Continuum 2024
June 9-11, 2024
Puerto Rico
IAS 2024
July 22-26
Munich, Germany
National LGBTQ+ Health Conference
August 15-17, 2024
Atlanta, GA
2024 National Ryan White Conference on HIV Care & Treatment
August 20-23, 2024
US Conference on HIV/AIDS (USCHA) 2024: Registration Open
September 12-15, 2024
New Orleans, LA
NEW – HIVR4P 2024, the 5th HIV Research for Prevention Conference (Registration Now Open and Application for Scholarships Available!)
October 6-10, 2024
Lima, Peru | Hybrid
For more DC CFAR events please see the calendar here.
| |
FUNDING, TRAINING, & MENTORING OPPORTUNITIES & SEMINARS | |
|
NEW – NIAID Virtual Grant Writing Webinar Series (Begins Feb 22nd, runs through July 18th): Register Now!
In this series of 6 webinars, we will discuss how to navigate your NIH grant application with emphasis on early career researchers - graduate students, postdoctoral fellows, clinician scientists and junior faculty. The webinars will provide information on the funding opportunities for early career researchers at NIAID, navigating the F, K, DP2 and R38/K38 awards and understanding the peer review process. Register here.
NEW – Ending the HIV Epidemic Webinar Series: PrEP Interventions with Black Communities, Feb 23, 12:30PM EST
Join the Implementation Science Coordination Initiative (ISCI) for our inaugural Ending the HIV Epidemic (EHE) Initiative Webinar Series: PrEP Interventions with Black Communities. Register here.
NEW – CFAR-Wide Webinar: “HVTN Vaccine Strategy Update” - Feb 26, 2024, 3:30PM EST
Please register here for this upcoming CFAR wide webinar featuring Dr. Larry Corey, UW/Fred Hutch CFAR, and his presentation entitled "HVTN Vaccine Strategy Update."
AVAC in Conversation with NIAID’s Jeanne Marrazzo, Feb 27, 11:30AM ET
"Join AVAC's Executive Director, Mitchell Warren, in conversation with the Director of NIAID, Jeanne Marrazzo, MD, MPH." Register here.
NEW – HIV and Drug Abuse Prevention Research Ethics Training Institute (RETI) Fellowship, Up to $30,000, Applications Due March 1st.
The Fordham University HIV and Drug Abuse Prevention Research Ethics Training Institute (RETI), awards $30,000 to accepted early career investigators to conduct an institute-funded research project on ethical issues in HIV and drug use research. For more information and eligiblity, use the link here.
NEW – Modelers and Storytellers: Transdisciplinary Training to Advance Community Health Intervention Research, Priority Deadline due March 11th
The Modelers and Storytellers Transdisciplinary Training is a two-week virtual summer research education program that will prepare predoctoral and postdoctoral trainees as well as early-career researchers to apply systems and/or data science methods to community-engaged health disparities research. The goal is to accelerate the translation of research into practice to address real-world, complex health issues especially as they relate to health disparities. Use the link here for more information and to apply.
Seeking Input on the Next NIH Strategic Plan for HIV and HIV-Related Research; RFI due by March 28, 2024
"The NIH Office of AIDS Research (OAR) has issued a Request for Information (RFI) as one source of input to inform development of the FY 2026‒2030 NIH Strategic Plan for HIV and HIV-Related Research. Feedback from all interested constituents—including, but not limited to, researchers, health care professionals, advocates and health advocacy organizations, scientific or professional organizations, public health officials, government agencies, and community members—is a critical part of this process." More information available here.
NEW – CDRF: 2024 CFAR HIV/AIDS Training Fellowship Awards, Seeking Indian National Applicant - Intent to Apply due by March 31st, 2024
CRDF Global is now accepting proposals from Centers for AIDS Research (CFARs) to support early-stage investigators from India working in the field of HIV/AIDS research for the 2024 CFAR HIV/AIDS Training Fellowship Awards. This two-year fellowship program aims to promote the training and inclusion of early-stage Indian scientists in HIV-related collaborative research within the CFAR program. Applications should come from CFARs and identify at least one Indian fellowship candidate. The initial intent to apply deadline is March 31, 2024; applications are due by July 31, 2024. For questions, please contact Annie King (aking@crdfglobal.org).
Workshop for Early Career Investigators in HIV, April 24, 2024, 11AM–4PM ET
The National Institutes of Health (NIH) Office of AIDS Research (OAR), along with the NIH institutes, centers, and offices (ICOs) with HIV research programs invite you to attend the Workshop for Early Career Investigators in HIV on Wednesday, April 24, 2024. OAR looks forward to building on the enthusiasm and feedback from the first two early career investigator (ECI) workshops in 2022 and 2023. OAR’s goal is to continue to provide knowledge, resources, and mentoring to the next generation of HIV investigators. Register here.
| |
NIH FUNDING OPPORTUNITIES
| |
|
HIV Cure-Related Research in Diverse Populations
Funding Opportunity Number: NOT-AI-23-046
Posting Date: June 23, 2023
Opening Date: September 07, 2023
Close Date: May 08, 2026
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-225
Posting Date: June 27, 2023
Opening Date: August 07, 2023
Close Date: Various – See announcement
Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-DK-25-001
Posting Date: November 30, 2023
Opening Date: February 20, 2024
Close Date: Various – See announcement
Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity Number: RFA-AI-23-060
Posting Date: October 25, 2023
Opening Date: February 13, 2024
Close Date: March 14, 2024
Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
Funding Opportunity Number: PAR-23-112
Posting Date: January 31, 2023
Opening Date: February 24, 2023
Close Date: Various – See announcement
Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional)
Funding Opportunity Number: RFA-DA-25-018
Posting Date: August 21, 2023
Opening Date: July 5, 2024
Close Date: August 2024
Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-DA-25-001
Posting Date: July 31, 2023
Opening Date: July 14, 2024
Close Date: August 14, 2024
Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required)
Funding Opportunity Number: RFA-OD-23-018
Posting Date: July 31, 2023
Opening Date: July 14, 2024
Close Date: August 14, 2024
| |
|
Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-297
Posting Date: September 19, 2023
Opening Date: December 07, 2023
Close Date: Various – See announcement
Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-22-185
Posting Date: May 27, 2022
Opening Date: December 07, 2023
Close Date: Various – See announcement
NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-198
Posting Date: June 02, 2023
Opening Date: September 13, 2023
Close Date: Various – See announcement
Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
Funding Opportunity Number: PAR-23-061
Posting Date: January 11, 2023
Opening Date: April 09, 2023
Close Date: January 10, 2026
Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)
Funding Opportunity Number: PAR-23-060
Posting Date: January 11, 2023
Opening Date: April 09, 2023
Close Date: January 10, 2026
Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
Funding Opportunity Number: NOT-MH-23-275
Posting Date: June 5, 2023
Opening Date: September 07, 2023
Close Date: September 08, 2026
Notice of Special Interest (NOSI): Research on HIV-associated Malignancies
Funding Opportunity Number: NOT-CA-23-070
Posting Date: June 5, 2023
Opening Date: September 07, 2023
Close Date: September 08, 2026
| |
Click here for additional funding opportunities available from the National Institutes of Health. | |
The DC CFAR is an NIH funded program (P30AI117970), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NIDCR, NHLBI, NIDA, NIMH, NIA, NIDDK, NINR, NIMHD, FIC, and OAR. The content isthe responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. | | |
| | | |
